feed info

12 articles from EurekAlert

Biological artificial organs like skin, vessels...now produced more easily

A Korean research group has developed a technology that allows for the differentiation of stem cells into desired cell types, such as vascular mural cells or osteoblasts, without special pretreatment. This technology is expected to facilitate the production of artificial organs for preclinical studies or artificial tissues for transplants such as artificial skin and cardiac patches.

Critically endangered macadamia species becomes a plant supermodel

The University of Queensland has developed a sophisticated plant genomic model, as part of a project to help conserve the critically endangered Macadamia jansenii.Discovered in 1982 by a Central Queensland farmer Ray Jansen, there are only Macadamia jansenii 100 trees in existence. The Australian bushfires nearly wiped out the entire population in 2019.Genomic mapping of the species will help in...

New Lancet series shows mixed progress on maternal and child undernutrition in last decade

Today, The Lancet published the latest Series on Maternal and Child Undernutrition Progress. Building upon findings from the previous 2008 and 2013 Series, which set the global agenda for tackling undernutrition over the past decade, this new Series concludes that despite modest progress in some areas, maternal and child undernutrition remains a major global health concern, specifically since...

Researchers develop improved recycling process for carbon fibres

The process retains properties of fibres at a higher rate than previous methods, demonstrating a retention strength of up to 90 percent.Recycling of composite materials could be up to 70 percent cheaper and lead to a 90-95 percent reduction in CO2 emissions compared to standard manufacturing.

Strong and balanced T cell response: key to controlling SARS-CoV-2 infection without getting COVID-19

Even though they show no signs of COVID-19, people with asymptomatic infections mount a virus-specific T-cell immune response, scientists at Duke-NUS Medical School and NUS Saw Swee Hock School of Public Health, Singapore, reported in the Journal of Experimental Medicine. The study findings show that these people produce a robust virus-specific T-cell response, which, in combination with...

Targeted immunotherapy could boost radiotherapy response

Profiling the 'immune landscape' of patient's tumours reveals who will most benefit from radiotherapy with potential immunotherapy in bowel cancer. Effectiveness of radiotherapy depends on the level of inflammation in tumors, before and after treatment. Tumors which are chronically Inflamed before treatment could be made more susceptible using targeted immunotherapies.